Cutaneous Manifestations of Endocrine Disease
Devika Icecreamwala
Department of Dermatology, Henry Ford Health System, Detroit, MI, USA
Search for more papers by this authorTor A. Shwayder
Department of Dermatology, Henry Ford Health System, Detroit, MI, USA
Search for more papers by this authorDevika Icecreamwala
Department of Dermatology, Henry Ford Health System, Detroit, MI, USA
Search for more papers by this authorTor A. Shwayder
Department of Dermatology, Henry Ford Health System, Detroit, MI, USA
Search for more papers by this authorPeter Hoeger
Search for more papers by this authorVeronica Kinsler
Search for more papers by this authorAlbert Yan
Search for more papers by this authorJohn Harper
Search for more papers by this authorArnold Oranje
Search for more papers by this authorChristine Bodemer
Search for more papers by this authorMargarita Larralde
Search for more papers by this authorVibhu Mendiratta
Search for more papers by this authorDiana Purvis
Search for more papers by this authorSummary
Paediatric endocrine disease may result in changes of the skin, hair, nails and mucosa. Cutaneous signs of congenital and acquired hypothyroidism include xerosis, thickening and doughy appearance of the skin, and brittleness of the hair. Hyperthyroidism with goiter often have skin changes which include facial flushing, hyperhidrosis and warm, moist skin. Increased serum cortisol can cause facial plethora, broad and purple striae, acne, acanthosis nigricans and skin thinning. Hyperpigmentation is seen with adrenal insufficiency. Androgen excess can present with weight gain, pubic and facial hair growth, acne, body odour and muscular habitus. Gynaecomastia is associated with hyperoestrogenism. Wrinkling of skin especially around the eyes and mouth can be seen in hypopituitarism, whereas gigantism/acromegaly is associated with hyperpituitarism. Hypoparathyroidism can result in dry skin, alopecia and brittle nails. Primary hyperparathyroidism can cause dehydration with skin tenting, prolonged capillary refill time and dry mucous membranes.
References
- Aversa T, Valenzise M, Corrias A et al. Underlying Hashimoto's thyroiditis negatively affects the evolution of subclinical hypothyroidism in children irrespectively of other concomitant risk factors. Thyroid 2015; 25: 183–7.
- Zimmerman MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol 2015; 3: 286–95.
- Yap WM, Chuah KL, Tan PH. Langerhans cell histiocytosis involving the thyroid and parathyroid gland. Mod Pathol 2001; 14: 111–5.
- Gahl W, Thoenone J, Schneider J. Cystinosis. N Engl J Med 2002; 347: 111–21.
- Huang SA, Tu HM, Harney JW. Severe hypothyroidism caused by type 3-iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000; 343: 185–9.
- Parks, JS, Lin M, Grosse SD. The impact of transient hypothyroidism on the increasing rate of congenital hypothyroidism in the United States. Pediatrics 2010; 125(Suppl 2): S54–63.
- Pagovich OE, Silverberg JI, Freilich E. Thyroid abnormalities in pediatric patients with vitiligo in New York City. Cutis 2008; 81: 463–6.
- Daven N, Doshi MD, Marianna L. Cutaneous manifestations of thyroid disease. Clin Dermatol 2008; 26: 283–87.
- Grant DB, Smith I, Fuggle PW et al. Congenital hypothyroidism detected by neonatal screening: relationship between biochemical severity and early clinical features. Arch Dis Child 1992; 67: 87–90.
- Leonhardt JM, Heymann WR. Thyroid disease and the skin. Dermatol Clin 2002; 20: 473–81.
- Oerbeck B, Sundet K, Kase BF et al. Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics 2003; 112: 923–30.
- LaFranchi SH, Austin J. How should we be treating children with congenital hypothyroidism? J Pediatr Endocrinol Metab 2007; 20: 559–78.
- Zakarija M, McKenzie JM, Eidson MS. Transient neonatal hypothyroidism: characterization of maternal antibodies to the thyrotropin receptor. J Clin Endocrinol Metab 1990; 70: 1239–46.
- Schoen EJ, Clapp W, To TT et al. The key role of newborn thyroid scintigraphy with isotopic iodide (123I) in defining and managing congenital hypothyroidism. Pediatrics 2004; 114: 683–8.
- Gabrilove JL, Ludwig AW. The histogenesis of myxoedema. J Clin Endocrinol Metab 1957; 17: 925–32.
- Bongers-Schokking JJ, Koot HM, Wiersma D et al. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000; 136; 293–7.
- Donaldson M, Jones J. Optimizing outcome in congenital hypothyroidism; current opinions on best practice in initial assessment and subsequent management. J Clin Res Pediatr Endocrinol 2013; 5(Suppl 1): 13–22.
- Bahn RS, Burch HB, Cooper DS et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 2011; 17: 456–520.
- Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid 1999; 9: 727–33.
- Leonhardt JM, Heymann WR. Thyroid disease and the skin. Dermatol Clin 2002; 20: 473–81.
- Vaidya VA, Bongiovanni AM, Parks JS et al. Twenty-two years experience in the medical management of juvenile thyrotoxicosis. Pediatrics 1974; 54: 565–70.
- Barnes HV, Blizzard RM. Antithyroid drug therapy for toxic diffuse goiter (Graves’ disease):thirty years experience in children and adolescents. J Pediatr 1977; 91: 313–20.
- Gorton C, Sadeghi-Nejad A, Senior B. Remission in children with hyperthyroidism treated with propylthiouracil. Am J Dis Child 1987; 141: 1084–6.
- Roberts CG, Ladenson PW. Hypothyroidism. Lancet 2004; 363: 1558.
- Truhan AP, Roenigk HH Jr. The cutaneous mucinoses. J Am Acad Dermatol 1986; 14: 1–18.
- US Preventative Service Task Force. Screening for thyroid disease: recommendation statement. Ann Intern Med 2004; 140: 125–7.
- Ishizawa T, Sugiki H, Anzai S et al. Pretibial myxedema with Graves’ disease: a case report and review of Japanese literature. J Dermatol 1998; 25: 264–8.
- Chang CC, Chang SC, Kao SC et al. Pentoxyfilline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves ophthalmopathy and pretibial myxoedema. Acta Endocrinol 1993; 129: 322–7.
- Antonelli A, Saracino A, Agastini S et al. Results of high-dose intravenous immunoglobulin treatment of patients with pretibial myxedema and Basedow's disease. Clin Ter 1992; 141: 63–8.
- Pineda AM, Tianco EA, Tan JB et al. Oral pentoxifylline and topical clobetasol propionate ointment in the treatment of pretibial myxoedema, with concomitant improvement of Grave's ophthalmopathy. J Eur Acad Dermatol Venereol 2007; 21: 1441–3.
References
- Magiakou MA, Mastorakos G, Oldfield EH et al. Cushing syndrome in children and adolescents. Presentation, diagnosis and therapy. N Engl J Med 1994; 331: 629–36.
- More J, Young J, Reznik Y et al. Ectopic ACTH syndrome in children and adolescents. J Clin Endocrinol Metab 2011; 96: 1213–22.
- Perry RJ, Findlay CA, Donaldson MD. Cushing's syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids. Arch Dis Chil 2002; 87: 14–8.
- Siklar Z, Bostanci I, Atli O. An infantile Cushing syndrome due to misuse of topical steroid. Pediatr Dermal 2004; 21: 561–3.
- Stratakis CA, Mastorakos G, Mitsiades NS et al. Skin manifestations of Cushing disease in children and adolescents before and after the resolution of hypercortisolemia. Pediatr Dermatol 1998; 15: 253–8.
- Alves C, Robazzi TC, Mendonca M et al. Withdrawal of glucosteroid therapy: clinical practice recommendations. J Pediatr 2008; 84: 192–202.
- Al-Himdani S, Ud-Din S, Gilmore S et al. Striae distensae: a comprehensive review and evidence-based evaluation of prophylaxis and treatment. Br J Dermatol 2014; 170: 527–47.
- Perry R, Kecha O, Paquette J et al. Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal. J Clin Endocrinol Metab 2005; 90: 3243–50.
- Lim YJ, Batch JA, Warne GL. Adrenal 21-hydroxylase deficiency in childhood: 25 years experience. J Paediatr Child Health 1995; 31: 222–7.
- Grant DB, Barnes ND, Moncrieff MW et al. Clinical presentation, growth and pubertal development in Addison's disease. Arch Dis Child 1985; 60: 925–8.
- Guo YK, Yang SG, Li Y et al. Addison's disease due to adrenal tuberculosis: contrast-enhanced CT features and clinical duration correlation. Eur J Radiol 2007; 62: 126–31.
References
- Viswanathan V, Eugster EA. Etiology and treatment of hypogonadism in adolescents. Endocrinol Metab Clin North Am 2009; 38: 719–38.
- Bhasin S, Cunningham GR, Hayes FJ et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95: 2536–59.
- Lowenstein EJ, Kim KH, Glick SA. Turner's syndrome in dermatology. J Am Acad Dermatol 2004; 50: 767–76.
- Ross JL, Quigley CA, Feuillan P et al. Growth hormone plus childhood low-dose estrogen in Turner's syndrome. N Engl J Med 2011; 364: 1230–42.
- Visootsak J, Aylstock M, Graham JM et al. Klinefelter syndrome and its variants: an update and review for the primary pediatrician. Clin Pediatr 2011; 40: 639–51.
- Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in the United States: implications for evaluation and treatment. Drug and Therapeutic and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics 1999; 104: 936–41.
- Wheeler MD, Styne DM. Diagnosis and management of precocious puberty. Pediatr Clin North Am 1990; 37: 1255–71.
- Choi JH, Shin YL, Yoo HW. Predictive factors for organic central precocious puberty and utility of simplified gonadotropin-releasing hormone tests. Pediatr Int 2007; 49: 806–10.
- Kaplowitz P. Clinical characteristics of 104 children referred for evaluation of precocious puberty. J Clin Endocrinol Metab 2004; 89: 3644–50.
- Chemaitilly W, Merchant TE, Li Z et al. Central precocious puberty following the diagnosis and treatment of pediatric cancer and central nervous system tumors: presentation and long-term outcomes. Clin Endocrinol 2016; 84: 361–71.
- Armengoud JB, Charkaluk ML, Trivin C et al. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. J Clin Endocrinol Metab 2009; 94: 2835–40.
- Feuillan PP, Foster CM, Pescovitz OH et al. Treatment of precocious puberty in the McCune–Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med 1986; 315: 1115–19.
- Eichenfield LF, Krakowki AC, Piggot C et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics 2013; 131: S163–86.
- Azziz R, Sanchez LA, Knochenhauer ES et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004; 89: 453–62.
- Cosma M, Swiglo BA, Flynn DN et al. Clinical review: Insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab 2008; 93: 1135–42.
- Hatch R, Rosenfield RL, Kim MH et al. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981; 140: 815–30.
- Lowenstein EJ. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome. Dermatol Ther 2006; 19: 210–23.
- Escobar-Morreale HF, Carmina E, Dewailly D et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 2012; 18: 146–70.
- Rosenfield RL, Lucky AW. Acne, hirsutism and alopecia in adolescent girls. Endocrinol Metab Clin North Am 1993; 22: 507–32.
- Shenenberger DW, Utecht LM. Removal of unwanted facial hair. Am Fam Physician 2002; 66: 1907–11.
- Azziz R, Hincapie LA, Knochenhauer ES et al. Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 1999; 72: 915–25.
- Solari A, Groisman B, Bidondo MP et al. Complete androgen insensitivity syndrome: diagnosis and clinical characteristics. Arch Argent Pediatr 2008; 106: 265–8.
- Wong RC, Ellis CN. Physiologic skin changes in pregnancy. J Am Acad Dermatol 1984; 10: 929–40.
- Nicol MR, Papacleovoulou G, Evans DB. Estrogen biosynthesis in human H296 adrenocortical carcinoma cells. Mol Cell Endocrinol 2009; 300: 115–20.
- Dejager S, Bry-Gauillard H, Bruckert E et al. A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocrinol Metab 2002; 87: 3893–901.
- Hughes IA, Davies JD, Bunch TI et al. Androgen insensitivity syndrome. Lancet 2012; 380: 1419–28.
- Winterborn MH, France NE, Raiti S. Incomplete testicular feminization. Arch Dis Child 1970; 45: 811–2.
- Wierman ME, Basson R, Davis SR, et al. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 2006; 91: 3697–710.
References
- Bollerslev J, Rejnmark L, Marcocci C et al. European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 2015; 173: G1–G20.
- Simpson JA. Dermatological changes in hypocalcaemia. Br J Dermatol 1954; 66: 1–15.
- LeBoeuf N, Garg A, Worobec S. The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Pediatr Dermatol 2007; 24: 529–33.
- Davies JH, Barton JS, Gregory JW et al. Infantile McCune-Albright syndrome. Pediatr Dermatol 2001; 18: 504–6.
- Burke JF, Chen H, Gosain A. Parathyroid conditions in childhood. Semin Pediatr Surg 2014; 23: 66–70.
- Tan O, Atik B, Kizilkava A et al. Extensive skin calcifications in an infant with chronic renal failure: metastatic calcinosis cutis. Pediatr Dermatol 2006; 23: 235–8.
- Feng J, Gohara M, Lazova R et al. Fatal childhood calciphylaxis in a 10-year-old and literature review. Pediatr Dermatol 2006; 23: 266–72.
- Sipple, JH. The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med 1961; 31: 163–6.
- Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86: 5658–71.
- Darling, TN, Skarulis MC, Steinberg MC et al. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 1997; 133: 853–7.
References
- Personnier C, Crosnier H, Meyer P et al. Prevalence of pituitary dysfunction after severe traumatic brain injury in children and adolescents: a large prospective study. J Clin Endocrinol Metab 2014; 99: 2052–60.
- Sklar CA. Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg 1994; 21(Suppl 1): 18–20.
- Toogood AA, Stewart PM. Hypopituitarism: clinical features, diagnosis, and management. Endocrinol Metab Clin North Am 2008; 37: 235–61.
- Argyropoulou MI, Kiortsis DN. MRI of the hypothalamic-pituitary axis in children. Pediatr Radiol 2005; 35: 1045–55.
- Colao A, Loche S, Cappabianca P. Pituitary adenomas in children and adolescents. Clinical presentation, diagnosis, and therapeutic strategies. The Endocrinologist 2000; 10: 314–27.
References
- Dabelea D, Mayer-Davis EJ, Saydah S et al. Prevalence of type 1 and 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014; 311: 1778–86.
- Ferringer T, Miller F 3rd. Cutaneous manifestation of diabetes mellitus. Dermatol Clin 2000: 20; 483–92.
- Sakai S, Kikuchi K, Satoh J et al. Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis. Br J Dermatol 2005; 153: 319–23.
- Ngo BT, Hayes KD, DiMiao DJ et al. Manifestations of cutaneous diabetic microangiopathy. Am J Clin Dermatol 2005; 225–37.
- Kakourou T, Dacou-Voutetakis C, Kavadias G et al. Limited joint mobility and lipodstyrophy in children and adolescents with insulin-dependent diabetes mellitus. Pediatr Dermatol 1994; 11: 310–4.
- Yosipovitch G, Hodak E, Vardi P et al. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetic risk factors and microvascular complications. Diabetes Care 1998; 21: 506–9.
- Lowitt MH, Dover JS. Necrobiosis lipoidica. J Am Acad Dermatol 1991; 25: 735–48.
- Verotti A, Chiarelli F, Amerio P et al. Necrobiosis lipoidica diabeticorum in children and adolescents: a clue for underlying renal and retinal disease. Pediatr Dermatol 1995; 12: 220–3.
- Szabo RM, Harris GD, Burke WA. Necrobiosis lipoidica in a 9-year-old girl with new-onset type II diabetes mellitus. Pediatr Dermatol 2001; 18: 316–9.
- Eddin DV. Cutaneous manifestations of diabetes mellitus in children. Pediatr Dermatol 1985; 2: 161–79.
- Fagot-Campagna A, Pettitt DJ, Engelgau MM et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000; 136: 664–72.
- Grinstein G, Muzumdar R, Aponte L et al. Presentation and 5-year follow-up of type 2 diabetes mellitus in African American and Carribean-Hispanic adolescents. Horm Res 2003; 60: 121–6.
- Clement S, Braithwaite SS, Magee MF et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27: 553–91.
- Romano G, Moretti G, Benedetto A et al. Skin lesions in diabetes mellitus: prevalence and clinical correlation. Diabetes Res Clin Pract 1998; 39: 101–6.
- Patterson R, Mellies CJ, Roberts M. Immunologic reactions against insulin to IgE anti-insulin, insulin allergy and combined IgE and IgG immunologic insulin resistance. J Immunol 1973; 110: 1135–45.
- de Villiers FP. Lipohypertrophy: a complication of insulin injections. S Afr Med J 2005; 95: 858–9.
- Lieberman P, Patterson R, Mertz R et al. Allergic reactions to insulin. JAMA 1971; 215: 1106–12.
- Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol 2003; 4: 661–7.
- American Diabetes Association. Type 2 Diabetes in children and adolescents. Diabetes Care 2000; 23; 381–9.
- Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation 2008; 117: 754–61.
- Levy-Marchal C, Arslanian S, Cutfield W et al. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab 2010; 95: 5189–98.
- Hirschler V, Ruiz A, Romero T et al. Comparison of different anthropometric indices for identifying insulin resistance in schoolchildren. Diabetes Technol Ther. 2009; 11: 615–21.
-
Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402–10.
10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S CAS PubMed Web of Science® Google Scholar
- Salpeter SR, Buckley NS, Kahn JA et al. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am J Med 2008; 121: 149–57.
References
- Tom WL, Playford MP, Admani S et al. Characterization of lipoprotein composition and function in pediatric psoriasis reveals a more atherogenic profile. J Invest Dermatol 2016; 136: 67–73.
- Akinci B, Koseoglu FD, Onay H et al. Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities. Metabolism 2015; 64: 1086–95.
- Agrawal AK, Kammen BF, Guo H et al. An unusual presentation of subcutaneous granuloma annulare in association with juvenile-onset diabetes: case report and literature review. Pediatr Dermatol 2012; 29: 202–5.
- Kahn CR, White MF. The insulin receptor and the molecular mechanism of insulin action. J Clin Invest 1988; 82: 1151–6.
- Poziomczyk CS, Bonamigo RR, Santa Maria FD et al. Clinical study of 20 patients with incontentia pigmenti. Int J Dermatol 2016; 5: 87–93.
- Przedborski S, Ferster A, Goldman S et al. Trichothiodystrophy, mental retardation, short stature, ataxia, and gonadal dysfunction in three Moroccan siblilngs. Am J Med Genet 1990; 35: 566–73.
- Goddard DS, Liang MG, Chamlin SL et al. Hypopituitarism in PHACES Association. Pediatr Dermatol 2006; 23: 476–80.
- Hufnagel RB, Arno G, Hein ND et al. Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence Moon syndromes. J Med Genet 2015; 52: 85–94.
- McCarthy PM, Piehler JM, Schaff HV et al. The significance of multiple, recurrent, and ‘complex’ cardiac myxomas. J Thorac Cardiovasc Surg 1986; 91: 389–96.
- Sardinoux M, Raingeard I, Bessis D et al. Cowden syndrome, or multiple hamartomatous tumor syndrome in clinical endocrinoloty. Ann Endocrinol 2010; 71: 264–73.
- Dworakowska D, Grossman AB. Are neuroendocrine tumors a feature of tuberous sclerosis? A systematic review. Endocr Relat Cancer 2009; 16: 45–58.
- Bizzarri C, Bottaro G. Endocrine implications of neurofibromatosis 1 in childhood. Horm Res Pediatr 2015; 83: 232–41.
- Amato MC, Elias LL, Elias J et al. Endocrine disorders in pediatric-onset Langerhans cell histiocytosis. Horm Metab Res 2006; 38: 746–51.
- Marina S, Broshilova V. POEMS in childhood. Pediatr Dermatol 2006; 23: 145–8.
- Vennos EM, Collins M, James WD. Rothmund-Thomson syndrome: review of the world literature. J Am Acad Dermatol 1992; 27: 750–62.
- Halabi-Tawil M, Ruemmele FM, Fraitag S et al. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Br J Dermatol 2009; 160: 645–51.
- Gupta V, Patra S, Firdaus Ali M et al. Sclerodermoid hypertrichotic plaques with insulin-dependent diabetes mellitus. Pediatr Dermatol 2015; 32: 731–2.
- Nanda A, Pasternack SM, Mahmoudi H et al. Alopecia and hypotrichosis as characteristic findings in Woodhouse-Sakati syndrome: report of a family with mutation in the C2orf37 gene. Pediatr Dermatol 2014; 31: 83–7.
- Kalkan E, Waguespack SG. Endocrine tumors associated with neurofibromatosis type 1, peutz-jeghers syndrome and other familial neoplasia syndromes. Front Horm Res 2013; 41: 166–81.
- Hawli Y, Nasrallah M, El-Haji Fuleihan G. Endocrine and musculoskeletal abnormalities in patients with Down syndrome. Nat Rev Endocrinol 2009; 5: 327–34.